All In Biotech

Drug Trial Radar · NCT00095316

Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

A Randomized, Double-Masked Trial of Caspofungin Versus Placebo as Prophylaxis of Invasive Candidiasis in High-Risk Adults in the Critical Care Setting

Last checked: Nov 20, 2026Latest source record: Dec 5, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 1,200 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

1,200

Planned (sponsor's estimate)

Start

Oct 2004

Primary completion

Not stated

Study completion Sep 2006

Sponsor

Sponsor type
NIH
First posted
Nov 3, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Adults admitted to intensive care units are at risk for a variety of complications. One of the most frequent complications is the development of new infections. Infections due to a fungus called Candida are of particular concern. This study will test the possibility that caspofungin, a new therapy for fungal infections, may reduce the rate of Candida infections in subjects at risk.

Conditions

  • Candidiasis

Interventions

  • CaspofunginDrug

    Caspofungin is an antifungal agent of the echinocandin class of glucan synthase inhibitor. Subjects receive Caspofungin acetate 50mg/day IV for 28 days.

  • PlaceboOther

    Normal saline equivalent to that used to deliver the caspofungin given intravenously as a single daily dose infused over approximately 1 hour for 28 days

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama Hospital - Infectious Diseases

    Birmingham, Alabama

  • University of Southern California - Infectious Diseases

    Los Angeles, California

  • Harbor UCLA Medical Center - Medicine - Infectious Diseases

    Torrance, California

  • University of Colorado Hospital - Denver

    Denver, Colorado

  • MedStar Washington Hospital Center - Infectious Diseases

    Washington D.C., District of Columbia

  • Jackson Memorial Hospital

    Miami, Florida

  • Emory University School of Medicine - Infectious Diseases

    Atlanta, Georgia

  • Rush University Medical Center

    Chicago, Illinois

  • University of Illinois at Chicago College of Medicine - Infectious Diseases

    Chicago, Illinois

  • The University of Chicago - Medicine - Infectious Diseases & Global Health

    Chicago, Illinois

  • Loyola University - Emergency Facility

    Maywood, Illinois

  • Infectious Disease of Indiana, PSC

    Indianapolis, Indiana

  • University of Kentucky - UK Albert B Chandler Hospital

    Lexington, Kentucky

  • Overton Brooks VA Medical Center

    Shreveport, Louisiana

  • Mark Hatfield Clinical Research Center

    Bethesda, Maryland

  • Tufts Medical Center - Infectious Diseases Clinic

    Boston, Massachusetts

  • University of Michigan - VA Ann Arbor Health Care Systems

    Ann Arbor, Michigan

  • Harper University Hospital

    Detroit, Michigan

  • Henry Ford Health System - Henry Ford Hospital

    Detroit, Michigan

  • University of Mississippi - Infectious Diseases

    Jackson, Mississippi

  • Cooper University Hospital - Infectious Diseases

    Camden, New Jersey

  • Duke University Medical Center - Duke Clinical Research Institute

    Durham, North Carolina

  • Memorial Hermann Hospital

    Houston, Texas

  • University of Texas Health Science Center at San Antonio - Infectious Diseases

    San Antonio, Texas

  • University of Virginia Primary Health Center - Infectious Diseases and International Health

    Charlottesville, Virginia

  • University of Wisconsin Hospital and Clinics - Clinical Science Center - Nephrology

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.